Month(s) | UTHAa (n = 160) | CTHAb (n = 164) | p value |
---|---|---|---|
At 1 | 79.14 ± 8.23 | 79.25 ± 7.59 | 0.236 |
At 3 | 87.64 ± 7.52 | 87.77 ± 7.63 | 0.062 |
At 6 | 89.14 ± 11.92 | 91.45 ± 9.57 | 0.041* |
At 12 | 88.75 ± 8.06 | 90.48 ± 8.91 | 0.043* |
At 13 | 88.11 ± 8.47 | 90.42 ± 9.02 | 0.040* |
At 15 | 87.54 ± 10.21 | 89.78 ± 9.83 | 0.042* |
At 18 | 86.38 ± 11.25 | 88.74 ± 8.32 | 0.038* |
At 24 | 85.56 ± 11.79 | 88.62 ± 9.01 | 0.036* |
At 25 | 85.29 ± 12.33 | 87.47 ± 10.58 | 0.042* |
At 27 | 84.54 ± 11.22 | 86.85 ± 12.15 | 0.043* |
At 30 | 82.63 ± 12.16 | 85.68 ± 13.72 | 0.037* |
At 36 | 81.66 ± 10.27 | 84.75 ± 9.75 | 0.036* |
At 37 | 80.11 ± 13.39 | 84.56 ± 11.47 | 0.032* |
At 39 | 78.76 ± 13.27 | 84.56 ± 12.53 | 0.029* |
At 42 | 78.16 ± 14.60 | 83.17 ± 13.29 | 0.030* |
At 48 | 77.13 ± 13.46 | 82.33 ± 12.02 | 0.032* |
At 49 | 76.12 ± 12.16 | 82.16 ± 13.10 | 0.027* |
At 51 | 75.31 ± 11.10 | 81.57 ± 10.39 | 0.014* |
At 54 | 76.65 ± 10.70 | 81.10 ± 8.02 | 0.011* |
At 60 | 75.92 ± 8.47 | 80.17 ± 7.06 | 0.013* |
At final follow-up | 74.09 ± 6.23 | 79.01 ± 10.21 | 0.012* |